Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06266702 · ClinicalTrials.gov registry record · NA
Evaluation of a Nutritional Technology for Vitamin D Absorption
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT06266702: Completed NA study, sponsored by Abbott Nutrition.
NCT06266702 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06266702, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This is a prospective, 2-group crossover, randomized, double-blind study to evaluate nutrient absorption.
Primary Outcome
Change in area under the curve (AUC) of serum vitamin D for low dose in experimental versus control oil
Interventions
- OTHER Experimental Oil with Phospholipids
- OTHER Control Polyunsaturated Oil Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2024-05-02 |
| Phase | NA |
What the finished NCT06266702 record still lists
NCT06266702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental Oil with Phospholipids is the first listed.
NCT06266702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06266702 about?
NCT06266702 is a clinical study titled "Evaluation of a Nutritional Technology for Vitamin D Absorption". This is a prospective, 2-group crossover, randomized, double-blind study to evaluate nutrient absorption.
What is the current status of trial NCT06266702?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2024-03-15. Estimated completion is 2024-05-02.
What interventions are being tested in trial NCT06266702?
The interventions under investigation include: Experimental Oil with Phospholipids (OTHER), Control Polyunsaturated Oil Blend (OTHER).
Who is sponsoring clinical trial NCT06266702?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06266702's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI